Predicted LncRNA
Download
DataTables
LncRNA
Compound
Cancer
P-value
Effect
ENSG00000272764.1
ABT-263 (navitoclax)
Cervical squamouscell carcinoma and endocervical adenocarcinoma
0.017961911
Resistant
ENSG00000272764.1
ABT-263 (navitoclax)
Breast invasive carcinoma
0.035274622
Sensitive